Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management

    January 2014 in “ Dermatology research and practice ”
    Kumutnart Chanprapaph, Vasanop Vachiramon, Ploysyne Rattanakaemakorn
    Studysummary This review discusses the presentation and management of skin toxicity from epidermal growth factor inhibitors, highlighting a correlation between cutaneous adverse effects and tumor response, but reports no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on downloads.hindawi.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Cutaneous Drug Eruptions Associated With the Use of New Oncological Drugs Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy · 2012
    2. The PRIDE Syndrome: Dermatological Side Effects of EGFR Inhibitors British Journal of Dermatology · 2006
    3. Nonscarring Inflammatory Alopecia Associated With the Epidermal Growth Factor Receptor Inhibitor Gefitinib Journal of the American Academy of Dermatology · 2006